Drugs / BMS-816336
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00979368 Comparator | Nov 2009 → Feb 2010 | hyperlipidemia, type 2 diabetes mellitus | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-816336 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00979368 ↗ |
| Modality | Small molecule | — CHEMBL4086816 ↗ |
| Route | Oral | “Suspension, Oral, 15 mg Active, Once on Day 1 only, 4 days” NCT00979368 ↗ |